Cassava Sciences Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SAVAW and buy or sell other stocks, ETFs, and their options commission-free!

About SAVAW

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. 

CEO
Richard Jon Barry
CEORichard Jon Barry
Employees
—
Employees—
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
1998
Founded1998
Employees
—
Employees—

SAVAW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
557.87K
Average volume557.87K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$11.02
52 Week high$11.02
52 Week low
$0.0203
52 Week low$0.0203

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.